Chromatin regulation genes, including KDM6A, KMT2D, EP300, and ARID1A, show high rates of mutation in bladder cancer, as demonstrated here and in multiple cohort studies [16]. The gene discussed is KMT2D; the disease is urinary bladder cancer.